Cross-Protective Peptide Vaccine against Influenza A Viruses Developed in HLA-A*2402 Human Immunity Model

Open Access

Peer-reviewed

Research Article

Toru Ichihashi,

Affiliation Department of Collaboration and Education, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan
⨯
Reiko Yoshida,

Affiliation Department of Global Epidemiology, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan
⨯
Chihiro Sugimoto,

Affiliation Department of Collaboration and Education, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan
⨯
Ayato Takada,

Affiliation Department of Global Epidemiology, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan
⨯
Kiichi Kajino

* E-mail: kiichi@czc.hokudai.ac.jp

Affiliation Department of Collaboration and Education, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan
⨯

Reader Comments (0)

Viral vaccines
Is the Subject Area "Viral vaccines" applicable to this article?

Thanks for your feedback.
Influenza A virus
Is the Subject Area "Influenza A virus" applicable to this article?

Thanks for your feedback.
Antigens
Is the Subject Area "Antigens" applicable to this article?

Thanks for your feedback.
Influenza
Is the Subject Area "Influenza" applicable to this article?

Thanks for your feedback.
Influenza viruses
Is the Subject Area "Influenza viruses" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
H5N1
Is the Subject Area "H5N1" applicable to this article?

Thanks for your feedback.